Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
30,672,048
-
Share change
-
-575,809
-
Total reported value
-
$148,760,000
-
Price per share
-
$4.85
-
Number of holders
-
49
-
Value change
-
-$4,336,391
-
Number of buys
-
25
-
Number of sells
-
41
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q3 2018
As of 30 Sep 2018,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,672,048 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Lyon Street Capital, LLC, ARMISTICE CAPITAL, LLC, Broadfin Capital, LLC, Opaleye Management Inc., Park West Asset Management LLC, SPHERA FUNDS MANAGEMENT LTD., Vivo Capital, LLC, and Harvest Capital Strategies LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.